tirzepatide news november 2025 New data show most patients now stay on Wegovy, Zepbound after a year New drug tirzepatide delivers significant Company of the Year 2025:

Diabetes 61(2):292300

Tracking your cycle using a calendar or period-tracking app during the first six months of treatment helps you and your provider distinguish expected adaptation from abnormal patterns that warrant investigation

For severe deficiency, clinicians typically prescribe loading doses daily or every other day for one to two weeks followed by monthly maintenance injections

Retatrutide is a triple agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, whereas semaglutide targets only GLP-1 and tirzepatide targets GLP-1 and GIP

Here are the pricing screen shots I took - they are offering $50 off your first month, or you can save by choosing the 3-month plan: What Medications Does Sprout Offer